Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Clinical trial NCT04105374 · WITHDRAWN

Trial details

NCT number: NCT04105374
Sponsor: NRG Oncology
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Glioblastoma Oligodendroglioma Supratentorial Glioblastoma

Start date: 2020-01-31
Primary completion: 2025-11-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.